 | • レポートコード：QYR2104Z3182 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、不眠症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非薬物療法、薬物療法）、用途別市場規模（病院、外来手術センター、在宅ケア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・不眠症治療の市場動向 ・企業の競争状況、市場シェア ・不眠症治療の種類別市場規模（非薬物療法、薬物療法） ・不眠症治療の用途別市場規模（病院、外来手術センター、在宅ケア） ・不眠症治療の北米市場規模2016-2027（アメリカ、カナダ） ・不眠症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・不眠症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・不眠症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・不眠症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck & Co.、Sanofi、Pfizer、Takeda Pharmaceutical Company Ltd.、Purdue Pharmaceuticals L.P.、Eisai, Co. Ltd.、Meda Consumer Healthcare、Pernix Therapeutics、Vanda Pharmaceuticals、ECR Pharmaceuticals、Fidia Farmaceutici、Dainippon Sumitomo、Biocodex、Eli Lilly and Company、Ebb Therapeutics） ・結論 |
Market Analysis and Insights: Global Insomnia Therapy Market
The global Insomnia Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Insomnia Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Insomnia Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Insomnia Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Insomnia Therapy market.
Global Insomnia Therapy Scope and Market Size
Insomnia Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Insomnia Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Non-pharmacological Therapy
Pharmacological Therapy
Segment by Application
Hospital
Ambulatory Surgical Center
Home Care
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Dainippon Sumitomo
Biocodex
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non-pharmacological Therapy
1.2.3 Pharmacological Therapy
1.3 Market by Application
1.3.1 Global Insomnia Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapy Market Perspective (2016-2027)
2.2 Insomnia Therapy Growth Trends by Regions
2.2.1 Insomnia Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Insomnia Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Insomnia Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Insomnia Therapy Industry Dynamic
2.3.1 Insomnia Therapy Market Trends
2.3.2 Insomnia Therapy Market Drivers
2.3.3 Insomnia Therapy Market Challenges
2.3.4 Insomnia Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapy Players by Revenue
3.1.1 Global Top Insomnia Therapy Players by Revenue (2016-2021)
3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Insomnia Therapy Revenue
3.4 Global Insomnia Therapy Market Concentration Ratio
3.4.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2020
3.5 Insomnia Therapy Key Players Head office and Area Served
3.6 Key Players Insomnia Therapy Product Solution and Service
3.7 Date of Enter into Insomnia Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapy Breakdown Data by Type
4.1 Global Insomnia Therapy Historic Market Size by Type (2016-2021)
4.2 Global Insomnia Therapy Forecasted Market Size by Type (2022-2027)
5 Insomnia Therapy Breakdown Data by Application
5.1 Global Insomnia Therapy Historic Market Size by Application (2016-2021)
5.2 Global Insomnia Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Insomnia Therapy Market Size (2016-2027)
6.2 North America Insomnia Therapy Market Size by Type
6.2.1 North America Insomnia Therapy Market Size by Type (2016-2021)
6.2.2 North America Insomnia Therapy Market Size by Type (2022-2027)
6.2.3 North America Insomnia Therapy Market Size by Type (2016-2027)
6.3 North America Insomnia Therapy Market Size by Application
6.3.1 North America Insomnia Therapy Market Size by Application (2016-2021)
6.3.2 North America Insomnia Therapy Market Size by Application (2022-2027)
6.3.3 North America Insomnia Therapy Market Size by Application (2016-2027)
6.4 North America Insomnia Therapy Market Size by Country
6.4.1 North America Insomnia Therapy Market Size by Country (2016-2021)
6.4.2 North America Insomnia Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Insomnia Therapy Market Size (2016-2027)
7.2 Europe Insomnia Therapy Market Size by Type
7.2.1 Europe Insomnia Therapy Market Size by Type (2016-2021)
7.2.2 Europe Insomnia Therapy Market Size by Type (2022-2027)
7.2.3 Europe Insomnia Therapy Market Size by Type (2016-2027)
7.3 Europe Insomnia Therapy Market Size by Application
7.3.1 Europe Insomnia Therapy Market Size by Application (2016-2021)
7.3.2 Europe Insomnia Therapy Market Size by Application (2022-2027)
7.3.3 Europe Insomnia Therapy Market Size by Application (2016-2027)
7.4 Europe Insomnia Therapy Market Size by Country
7.4.1 Europe Insomnia Therapy Market Size by Country (2016-2021)
7.4.2 Europe Insomnia Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapy Market Size (2016-2027)
8.2 Asia-Pacific Insomnia Therapy Market Size by Type
8.2.1 Asia-Pacific Insomnia Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Insomnia Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Insomnia Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Insomnia Therapy Market Size by Application
8.3.1 Asia-Pacific Insomnia Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Insomnia Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Insomnia Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Insomnia Therapy Market Size by Region
8.4.1 Asia-Pacific Insomnia Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Insomnia Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Insomnia Therapy Market Size (2016-2027)
9.2 Latin America Insomnia Therapy Market Size by Type
9.2.1 Latin America Insomnia Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Insomnia Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Insomnia Therapy Market Size by Type (2016-2027)
9.3 Latin America Insomnia Therapy Market Size by Application
9.3.1 Latin America Insomnia Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Insomnia Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Insomnia Therapy Market Size by Application (2016-2027)
9.4 Latin America Insomnia Therapy Market Size by Country
9.4.1 Latin America Insomnia Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Insomnia Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapy Market Size (2016-2027)
10.2 Middle East & Africa Insomnia Therapy Market Size by Type
10.2.1 Middle East & Africa Insomnia Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Insomnia Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Insomnia Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Insomnia Therapy Market Size by Application
10.3.1 Middle East & Africa Insomnia Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Insomnia Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Insomnia Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Insomnia Therapy Market Size by Country
10.4.1 Middle East & Africa Insomnia Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Insomnia Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Details
11.1.2 Merck & Co. Business Overview
11.1.3 Merck & Co. Insomnia Therapy Introduction
11.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2016-2021)
11.1.5 Merck & Co. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Insomnia Therapy Introduction
11.2.4 Sanofi Revenue in Insomnia Therapy Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Insomnia Therapy Introduction
11.3.4 Pfizer Revenue in Insomnia Therapy Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Takeda Pharmaceutical Company Ltd.
11.4.1 Takeda Pharmaceutical Company Ltd. Company Details
11.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
11.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2016-2021)
11.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.5 Purdue Pharmaceuticals L.P.
11.5.1 Purdue Pharmaceuticals L.P. Company Details
11.5.2 Purdue Pharmaceuticals L.P. Business Overview
11.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
11.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2016-2021)
11.5.5 Purdue Pharmaceuticals L.P. Recent Development
11.6 Eisai, Co. Ltd.
11.6.1 Eisai, Co. Ltd. Company Details
11.6.2 Eisai, Co. Ltd. Business Overview
11.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
11.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2016-2021)
11.6.5 Eisai, Co. Ltd. Recent Development
11.7 Meda Consumer Healthcare
11.7.1 Meda Consumer Healthcare Company Details
11.7.2 Meda Consumer Healthcare Business Overview
11.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
11.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2016-2021)
11.7.5 Meda Consumer Healthcare Recent Development
11.8 Pernix Therapeutics
11.8.1 Pernix Therapeutics Company Details
11.8.2 Pernix Therapeutics Business Overview
11.8.3 Pernix Therapeutics Insomnia Therapy Introduction
11.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2016-2021)
11.8.5 Pernix Therapeutics Recent Development
11.9 Vanda Pharmaceuticals
11.9.1 Vanda Pharmaceuticals Company Details
11.9.2 Vanda Pharmaceuticals Business Overview
11.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
11.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2016-2021)
11.9.5 Vanda Pharmaceuticals Recent Development
11.10 ECR Pharmaceuticals
11.10.1 ECR Pharmaceuticals Company Details
11.10.2 ECR Pharmaceuticals Business Overview
11.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
11.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2016-2021)
11.10.5 ECR Pharmaceuticals Recent Development
11.11 Fidia Farmaceutici
11.11.1 Fidia Farmaceutici Company Details
11.11.2 Fidia Farmaceutici Business Overview
11.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
11.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2016-2021)
11.11.5 Fidia Farmaceutici Recent Development
11.12 Dainippon Sumitomo
11.12.1 Dainippon Sumitomo Company Details
11.12.2 Dainippon Sumitomo Business Overview
11.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
11.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2016-2021)
11.12.5 Dainippon Sumitomo Recent Development
11.13 Biocodex
11.13.1 Biocodex Company Details
11.13.2 Biocodex Business Overview
11.13.3 Biocodex Insomnia Therapy Introduction
11.13.4 Biocodex Revenue in Insomnia Therapy Business (2016-2021)
11.13.5 Biocodex Recent Development
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Details
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Insomnia Therapy Introduction
11.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2016-2021)
11.14.5 Eli Lilly and Company Recent Development
11.15 Ebb Therapeutics
11.15.1 Ebb Therapeutics Company Details
11.15.2 Ebb Therapeutics Business Overview
11.15.3 Ebb Therapeutics Insomnia Therapy Introduction
11.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2016-2021)
11.15.5 Ebb Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Insomnia Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non-pharmacological Therapy
Table 3. Key Players of Pharmacological Therapy
Table 4. Global Insomnia Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Insomnia Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Insomnia Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Insomnia Therapy Market Share by Regions (2016-2021)
Table 8. Global Insomnia Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Insomnia Therapy Market Share by Regions (2022-2027)
Table 10. Insomnia Therapy Market Trends
Table 11. Insomnia Therapy Market Drivers
Table 12. Insomnia Therapy Market Challenges
Table 13. Insomnia Therapy Market Restraints
Table 14. Global Insomnia Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Insomnia Therapy Market Share by Players (2016-2021)
Table 16. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Therapy as of 2020)
Table 17. Ranking of Global Top Insomnia Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Insomnia Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Insomnia Therapy Product Solution and Service
Table 21. Date of Enter into Insomnia Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Insomnia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Insomnia Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Insomnia Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Insomnia Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Insomnia Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Insomnia Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Insomnia Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Insomnia Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Insomnia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Insomnia Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Insomnia Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Insomnia Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Insomnia Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Insomnia Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Insomnia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Insomnia Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Insomnia Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Insomnia Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Insomnia Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Insomnia Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Insomnia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Insomnia Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Insomnia Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Insomnia Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Insomnia Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Insomnia Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Insomnia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Insomnia Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Insomnia Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Insomnia Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Insomnia Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Insomnia Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Insomnia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Insomnia Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Insomnia Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Insomnia Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Insomnia Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Insomnia Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck & Co. Company Details
Table 62. Merck & Co. Business Overview
Table 63. Merck & Co. Insomnia Therapy Product
Table 64. Merck & Co. Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 65. Merck & Co. Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Insomnia Therapy Product
Table 69. Sanofi Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Insomnia Therapy Product
Table 74. Pfizer Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Takeda Pharmaceutical Company Ltd. Company Details
Table 77. Takeda Pharmaceutical Company Ltd. Business Overview
Table 78. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product
Table 79. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 80. Takeda Pharmaceutical Company Ltd. Recent Development
Table 81. Purdue Pharmaceuticals L.P. Company Details
Table 82. Purdue Pharmaceuticals L.P. Business Overview
Table 83. Purdue Pharmaceuticals L.P. Insomnia Therapy Product
Table 84. Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 85. Purdue Pharmaceuticals L.P. Recent Development
Table 86. Eisai, Co. Ltd. Company Details
Table 87. Eisai, Co. Ltd. Business Overview
Table 88. Eisai, Co. Ltd. Insomnia Therapy Product
Table 89. Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 90. Eisai, Co. Ltd. Recent Development
Table 91. Meda Consumer Healthcare Company Details
Table 92. Meda Consumer Healthcare Business Overview
Table 93. Meda Consumer Healthcare Insomnia Therapy Product
Table 94. Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 95. Meda Consumer Healthcare Recent Development
Table 96. Pernix Therapeutics Company Details
Table 97. Pernix Therapeutics Business Overview
Table 98. Pernix Therapeutics Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 99. Pernix Therapeutics Recent Development
Table 100. Vanda Pharmaceuticals Company Details
Table 101. Vanda Pharmaceuticals Business Overview
Table 102. Vanda Pharmaceuticals Insomnia Therapy Product
Table 103. Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 104. Vanda Pharmaceuticals Recent Development
Table 105. ECR Pharmaceuticals Company Details
Table 106. ECR Pharmaceuticals Business Overview
Table 107. ECR Pharmaceuticals Insomnia Therapy Product
Table 108. ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 109. ECR Pharmaceuticals Recent Development
Table 110. Fidia Farmaceutici Company Details
Table 111. Fidia Farmaceutici Business Overview
Table 112. Fidia Farmaceutici Insomnia Therapy Product
Table 113. Fidia Farmaceutici Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 114. Fidia Farmaceutici Recent Development
Table 115. Dainippon Sumitomo Company Details
Table 116. Dainippon Sumitomo Business Overview
Table 117. Dainippon Sumitomo Insomnia Therapy Product
Table 118. Dainippon Sumitomo Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 119. Dainippon Sumitomo Recent Development
Table 120. Biocodex Company Details
Table 121. Biocodex Business Overview
Table 122. Biocodex Insomnia Therapy Product
Table 123. Biocodex Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 124. Biocodex Recent Development
Table 125. Eli Lilly and Company Company Details
Table 126. Eli Lilly and Company Business Overview
Table 127. Eli Lilly and Company Insomnia Therapy Product
Table 128. Eli Lilly and Company Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 129. Eli Lilly and Company Recent Development
Table 130. Ebb Therapeutics Company Details
Table 131. Ebb Therapeutics Business Overview
Table 132. Ebb Therapeutics Insomnia Therapy Product
Table 133. Ebb Therapeutics Revenue in Insomnia Therapy Business (2016-2021) & (US$ Million)
Table 134. Ebb Therapeutics Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Insomnia Therapy Market Share by Type: 2020 VS 2027
Figure 2. Non-pharmacological Therapy Features
Figure 3. Pharmacological Therapy Features
Figure 4. Global Insomnia Therapy Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Ambulatory Surgical Center Case Studies
Figure 7. Home Care Case Studies
Figure 8. Insomnia Therapy Report Years Considered
Figure 9. Global Insomnia Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Insomnia Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Insomnia Therapy Market Share by Regions: 2020 VS 2027
Figure 12. Global Insomnia Therapy Market Share by Regions (2022-2027)
Figure 13. Global Insomnia Therapy Market Share by Players in 2020
Figure 14. Global Top Insomnia Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Therapy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Insomnia Therapy Revenue in 2020
Figure 16. Global Insomnia Therapy Revenue Market Share by Type (2016-2021)
Figure 17. Global Insomnia Therapy Revenue Market Share by Type (2022-2027)
Figure 18. North America Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Insomnia Therapy Market Share by Type (2016-2027)
Figure 20. North America Insomnia Therapy Market Share by Application (2016-2027)
Figure 21. North America Insomnia Therapy Market Share by Country (2016-2027)
Figure 22. United States Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Insomnia Therapy Market Share by Type (2016-2027)
Figure 26. Europe Insomnia Therapy Market Share by Application (2016-2027)
Figure 27. Europe Insomnia Therapy Market Share by Country (2016-2027)
Figure 28. Germany Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Insomnia Therapy Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Insomnia Therapy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Insomnia Therapy Market Share by Region (2016-2027)
Figure 38. China Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Insomnia Therapy Market Share by Type (2016-2027)
Figure 46. Latin America Insomnia Therapy Market Share by Application (2016-2027)
Figure 47. Latin America Insomnia Therapy Market Share by Country (2016-2027)
Figure 48. Mexico Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Insomnia Therapy Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Insomnia Therapy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Insomnia Therapy Market Share by Country (2016-2027)
Figure 54. Turkey Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Insomnia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck & Co. Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 58. Sanofi Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 60. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 61. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 62. Eisai, Co. Ltd. Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 63. Meda Consumer Healthcare Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 64. Pernix Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 65. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 66. ECR Pharmaceuticals Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 67. Fidia Farmaceutici Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 68. Dainippon Sumitomo Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 69. Biocodex Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 70. Eli Lilly and Company Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 71. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapy Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の不眠症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Insomnia Therapy Market The global Insomnia Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a b…- 世界の不眠症薬理学的治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Insomnia Pharmacological Treatment Market The global Insomnia Pharmacological Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high …
- 世界の不眠症市場規模・現状・予測（2021年-2027年） Insomnia is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood. Sleep hygiene and lifestyle changes are typically the …
- 世界の外来用点滴療法サービス市場規模・現状・予測（2021年-2027年） Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications. Ambulatory infusion therapy is a flourishing nationwide trend. Due to a confluence of health ca…
- 世界の家庭用・代替部位注入療法市場規模・現状・予測（2021年-2027年） Home and specialty infusion is a vast arena of pharmaceutical services provided in the outpatient setting, typically in the patient’s home or an infusion suite. The majority of these medications involve administration through a needle or catheter, otherwise known as infusion, while others are admini…